AIMN:ATLAS maps the global biopharma regulatory landscape in real time — 65 tracked companies positioned at their operational headquarters, overlaid with 11 heat zones showing current approval velocity at every major drug agency, from FDA and EMA to SFDA and PMDA.
Zone color intensity reflects each agency's current score: how fast approvals are moving, how many active reviews are in flight, and where signals are clustering. The live feed on the right pulls continuously from three independent sources — AIMN Archive, OpenFDA, and ClinicalTrials.gov — surfacing NDA filings, BLA submissions, PDUFA date shifts, and Phase III enrollment events as they happen.
This is not a dashboard of curated summaries. It is the underlying signal layer.
AIMN:ATLAS is built for professionals who need to move intelligence, not just consume it. Every mechanism below is designed to make it easy to hand off a signal, share a regulatory moment with your team, or document a finding worth tracking.
Intelligence is only useful when it moves. These tools exist so that what you see on ATLAS doesn't stay in your browser tab.